Related content

A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells

By        

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 867-872

Spandidos Publications

Access to resources Recommend Favorite

Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer

By Onoue Masahide   Terada Tomohiro   Okuda Masahiro   Fujimoto Koji   Doi Ryuichiro   Imamura Masayuki   Inui Ken-ichi  

International Journal of Clinical Oncology, Vol. 9, Iss. 3, 2004-06 ,pp. : 174-178

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 599-602

Spandidos Publications

Access to resources Recommend Favorite

FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1482-1488

Spandidos Publications

Access to resources Recommend Favorite